On April 8, the 91st China International Medical Equipment Fair (CMEF) opened. During the exhibition, Midea Medical held the "AI All-dimensional Intelligent Transformation 2025 Midea Medical Annual New Product Release and China Backbone Guardian Plan Launch Meeting" and officially announced the establishment of Midea Medical Division.

As one of the six major business sectors of Midea Group, Midea Medical is a major breakthrough in Midea Group's diversified development strategy. Midea Medical has the accumulation of Wandong Medical in medical diagnostic equipment and intelligent imaging solutions, Kuka Medical's cutting-edge technology in the field of surgical robots and rehabilitation robots, Midea Biomedical's professional advantages in medical cold chain refrigeration, Swisslog Medical's mature solutions in hospital logistics and pharmacy automation, and Midea Building Technology's strength in the construction and operation of smart hospitals. The synergy of these advantageous resources will further enhance Midea Medical's industrial competitiveness. Midea Medical will also rely on Midea Medical Device Research Institute, AI Research Institute and Wandong Medical Research Institute to comprehensively enhance Midea Medical's R&D strength in the medical field, continue to increase R&D investment to break through the technical barriers of core products, enhance the competitiveness of Midea Medical's core products, and expand the boundaries of medical services. Focusing on the core concept of "technology for good, health without boundaries", it will seek new industrial opportunities worldwide.

Wandong Medical is the core force in the field of medical imaging under Midea Medical. It has high-quality imaging and cutting-edge AI technology. During the exhibition, it released four innovative product matrices and a smart solution. Among them, the third-generation liquid helium-free magnetic resonance breaks the bottleneck of liquid helium resource dependence, reduces the operating cost and maintenance difficulty of hospital equipment, improves the efficiency of the entire chain of scanning and diagnosis through intelligence, and reduces patient waiting time. Wanliyun has built a closed loop of digital medical ecology with "equipment + AI cloud". The Miaobi AI-report generation system can complete the report (initial diagnosis) in about one and a half minutes based on the doctor's description of the lesion. The orthopedic solution provides orthopedics with multi-dimensional imaging equipment and AI empowerment, such as intelligent Cobb angle automatic measurement, intelligent lower limb force line automatic measurement, AI image quality control, AI report quality control and other intelligent tools, covering the entire process and multiple nodes to meet different orthopedic diagnosis and treatment needs.

Midea Biomedical is comprehensively expanding its low-temperature storage equipment biosafety business, providing a variety of technologies, products and industry scenario solutions including smart vaccine boxes, blood refrigerators, medical refrigerators, medical refrigerated freezers, and ultra-low temperature frozen storage boxes. At this exhibition, Midea Biomedical displayed products such as automated sample library storage equipment, -86℃ Ruiyun ultra-low temperature preservation boxes, and air-controlled humidity medical refrigerators. It also revealed that the company is developing the "Boundless" series of Stirling refrigeration ultra-low temperature preservation boxes: with high refrigeration efficiency, precise temperature control, and strong anti-interference.

Midea Building Technology is committed to becoming a full-life cycle partner of smart hospitals, building a full industrial chain system for smart hospitals, and continuously simplifying the non-diagnosis and treatment processes of hospitals to make hospitals smarter and more energy-efficient.
In addition, Midea Medical also announced the launch of the China Backbone Protection Plan to promote the popularization of adolescent spinal health screening, precision diagnosis and treatment, and normalization of intervention, and to create a benchmark case combining medical technology with public welfare.

https://finance.eastmoney.com/a/202504093371341959.html